JPMorgan Chase & Co’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187 | Hold |
26
| – | – | ﹤0.01% | 5897 |
|
|
2025
Q1 | $215 | Hold |
26
| – | – | ﹤0.01% | 5913 |
|
|
2024
Q4 | $1.04K | Hold |
26
| – | – | ﹤0.01% | 5671 |
|
|
2024
Q3 | $225 | Sell |
26
-1
| -4% | -$9 | ﹤0.01% | 5823 |
|
|
2024
Q2 | $237 | Hold |
27
| – | – | ﹤0.01% | 5743 |
|
|
2024
Q1 | $663 | Hold |
27
| – | – | ﹤0.01% | 5670 |
|
|
2023
Q4 | $450 | Hold |
27
| – | – | ﹤0.01% | 5901 |
|
|
2023
Q3 | $506 | Hold |
27
| – | – | ﹤0.01% | 5765 |
|
|
2023
Q2 | $657 | Hold |
27
| – | – | ﹤0.01% | 5604 |
|
|
2023
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 5616 |
|
|
2022
Q4 | $1K | Sell |
27
-125
| -82% | -$4.63K | ﹤0.01% | 5418 |
|
|
2022
Q3 | $5K | Buy |
152
+89
| +141% | +$2.93K | ﹤0.01% | 5179 |
|
|
2022
Q2 | $2K | Sell |
63
-524
| -89% | -$16.6K | ﹤0.01% | 5402 |
|
|
2022
Q1 | $31K | Buy |
587
+12
| +2% | +$634 | ﹤0.01% | 5154 |
|
|
2021
Q4 | $170K | Sell |
575
-52
| -8% | -$15.4K | ﹤0.01% | 4612 |
|
|
2021
Q3 | $244K | Sell |
627
-409
| -39% | -$159K | ﹤0.01% | 4317 |
|
|
2021
Q2 | $529K | Sell |
1,036
-145
| -12% | -$74K | ﹤0.01% | 3959 |
|
|
2021
Q1 | $672K | Sell |
1,181
-406
| -26% | -$231K | ﹤0.01% | 3878 |
|
|
2020
Q4 | $1.1M | Buy |
+1,587
| New | +$1.1M | ﹤0.01% | 3324 |
|